Locations:
October 7, 2022/News Updates

Cleveland Clinic Opens Phone Line for Community Monkeypox Vaccinations

Vaccine Generic

Cleveland Clinic has opened up a phone line for individuals to be assessed for monkeypox vaccination, regardless of whether they are a Cleveland Clinic patient. Individuals can call 216-444-2538 and say they are interested in monkeypox vaccination. The infectious disease clinic will contact them to arrange an appointment at Cleveland Clinic main campus with an ID provider who will evaluate and administer the vaccine if appropriate. Current Cleveland Clinic patients interested in monkeypox vaccination should discuss it with their primary care physician.

Monkeypox is a viral illness that causes flu-like symptoms, such as a fever, body aches and chills, and a rash that can be painful. The CDC currently recommends vaccination for individuals 18 years and older who are at high risk for a monkeypox infection. In August, the World Health Organization declared monkeypox a global public health emergency with cases being reported in many different countries, including in the United States. More than 250 cases have been confirmed in Ohio. It is most commonly transmitted by skin-to-skin contact with an infected individual.

Latest from the Newsroom

Cleveland Clinic's new teaching kitchen and food pantry at the Langston Hughes Community Health & Education Center

Cleveland Clinic Opens Teaching Kitchen and Food Pantry on Cleveland's East Side

VeloSano riders

$20.2 Million Raised for VeloSano, Funding Cancer Research at Cleveland Clinic in 2026

Photo of spine imaging.

Cleveland Clinic Expands Orthopaedic Care in the Mahoning Valley Through Acquisition of Youngstown Orthopaedic Associates Practice

Lobby of new Toronto location

Cleveland Clinic Canada Moves to New Downtown Toronto Location

Artist's rendering of gene therapy for high triglycerides.

Gene Editing Therapy Trial Dramatically Lowers Dangerous Blood Fat Levels

Artist's illustration of gene editing

Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective

Medical illustration of lipoprotein(a) molecule

Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years

Ali Aminian, M.D., performing bariatric surgery.

Cleveland Clinic Study Finds Bariatric Surgery Effective for Substantial Weight Loss After GLP-1 Intolerance or Limited Weight Loss